U.S. Senate · 117th Congress · S. 898
Fair Accountability and Innovative Research Drug Pricing Act of 2021
A bill to require reporting regarding certain drug price increases, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Tammy BaldwinD-WI
- Introduced
- March 23, 2021, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (5)
3 Republicans, 2 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Mike BraunR-IN
- Lisa MurkowskiR-AK
- Tina SmithD-MN
Signed on later
- John HoevenR-NDJune 9, 2021
- Angus S. King, Jr.D-MEJune 9, 2021